Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Gabriel

Showing results (321-330 of 459) with videos related to

Pageof 46
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 10, 2010
Causes of death in early MI survivors with persistent infarct artery occlusion: results from the Occluded Artery Trial (OAT)Irene M Lang, Sandra A Forman, Aldo P Maggioni, et al.
JACC. Cardiovascular Interventions|September 24, 2016
Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX TrialJérémie Abtan, P Gabriel Steg, Gregg W Stone, et al.
Mayo Clinic Proceedings|October 21, 2017
25-Year Physical Activity Trajectories and Development of Subclinical Coronary Artery Disease as Measured by Coronary Artery Calcium: The Coronary Artery Risk Development in Young Adults (CARDIA) StudyDeepika R Laddu, Jamal S Rana, Rosenda Murillo, et al.
Revista Espanola De Cardiologia|March 10, 2009
ESC guidelines on management of acute myocardial infarction in patients presenting with persistent ST-segment elevation, Frans Van de Werf, Jeroen Bax, et al.
European Heart Journal|November 14, 2008
Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of CardiologyFrans Van de Werf, Jeroen Bax, Amadeo Betriu, et al.
The American Journal of Cardiology|May 12, 2009
Clinical outcomes of patients with diabetic nephropathy randomized to clopidogrel plus aspirin versus aspirin alone (a post hoc analysis of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance [CHARISMA] trial)Arijit Dasgupta, Steven R Steinhubl, Deepak L Bhatt, et al.
Clinical Cardiology|May 27, 2021
The effect of sex on the efficacy and safety of dual antithrombotic therapy with dabigatran versus triple therapy with warfarin after PCI in patients with atrial fibrillation (a RE-DUAL PCI subgroup analysis and comparison to other dual antithrombotic therapy trials)David S Eccleston, Joseph M Kim, Jurien M Ten Berg, et al.
The New England Journal of Medicine|August 28, 2018
Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical IllnessAlex C Spyropoulos, Walter Ageno, Gregory W Albers, et al.
Circulation|November 1, 2017
Frequency, Predictors, and Impact of Combined Antiplatelet Therapy on Venous Thromboembolism in Patients With Symptomatic AtherosclerosisIlaria Cavallari, David A Morrow, Mark A Creager, et al.
Journal of the American College of Cardiology|June 27, 2020
Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill PatientsAlex C Spyropoulos, Walter Ageno, Gregory W Albers, et al.
Pageof 46

Showing results (321-330 of 459) with videos related to

Sort By:
Pageof 46
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 10, 2010
Causes of death in early MI survivors with persistent infarct artery occlusion: results from the Occluded Artery Trial (OAT)Irene M Lang, Sandra A Forman, Aldo P Maggioni, et al.
JACC. Cardiovascular Interventions|September 24, 2016
Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX TrialJérémie Abtan, P Gabriel Steg, Gregg W Stone, et al.
Mayo Clinic Proceedings|October 21, 2017
25-Year Physical Activity Trajectories and Development of Subclinical Coronary Artery Disease as Measured by Coronary Artery Calcium: The Coronary Artery Risk Development in Young Adults (CARDIA) StudyDeepika R Laddu, Jamal S Rana, Rosenda Murillo, et al.
Revista Espanola De Cardiologia|March 10, 2009
ESC guidelines on management of acute myocardial infarction in patients presenting with persistent ST-segment elevation, Frans Van de Werf, Jeroen Bax, et al.
European Heart Journal|November 14, 2008
Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of CardiologyFrans Van de Werf, Jeroen Bax, Amadeo Betriu, et al.
The American Journal of Cardiology|May 12, 2009
Clinical outcomes of patients with diabetic nephropathy randomized to clopidogrel plus aspirin versus aspirin alone (a post hoc analysis of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance [CHARISMA] trial)Arijit Dasgupta, Steven R Steinhubl, Deepak L Bhatt, et al.
Clinical Cardiology|May 27, 2021
The effect of sex on the efficacy and safety of dual antithrombotic therapy with dabigatran versus triple therapy with warfarin after PCI in patients with atrial fibrillation (a RE-DUAL PCI subgroup analysis and comparison to other dual antithrombotic therapy trials)David S Eccleston, Joseph M Kim, Jurien M Ten Berg, et al.
The New England Journal of Medicine|August 28, 2018
Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical IllnessAlex C Spyropoulos, Walter Ageno, Gregory W Albers, et al.
Circulation|November 1, 2017
Frequency, Predictors, and Impact of Combined Antiplatelet Therapy on Venous Thromboembolism in Patients With Symptomatic AtherosclerosisIlaria Cavallari, David A Morrow, Mark A Creager, et al.
Journal of the American College of Cardiology|June 27, 2020
Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill PatientsAlex C Spyropoulos, Walter Ageno, Gregory W Albers, et al.
Pageof 46